Acutus Medical Inc (AFIB) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Acutus Medical Inc (AFIB) has a cash flow conversion efficiency ratio of 0.350x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.06 Million) by net assets ($-11.59 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Acutus Medical Inc (AFIB) balance sheet quality index to measure how much of total assets are equity-financed.
Acutus Medical Inc - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Acutus Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Acutus Medical Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Acutus Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Acutus Medical Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Devolver Digital Inc
LSE:DEVO
|
0.037x |
|
Teras Resources Inc
V:TRA
|
0.129x |
|
Condmag Brasov
RO:COMI
|
0.042x |
|
Geneuro SA
PA:GNRO
|
0.393x |
|
Eurasia Mining
LSE:EUA
|
0.032x |
|
Lake Winn Resources Corp
V:LWR
|
0.048x |
|
Urbanimmersive Inc
V:UI
|
-0.002x |
|
Robert Walters
LSE:RWA
|
0.065x |
Annual Cash Flow Conversion Efficiency for Acutus Medical Inc (2018–2024)
The table below shows the annual cash flow conversion efficiency of Acutus Medical Inc from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see Acutus Medical Inc market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-11.59 Million | $-31.66 Million | 2.731x | -96.20% |
| 2023-12-31 | $-879.00K | $-63.12 Million | 71.807x | +6435.10% |
| 2022-12-31 | $75.02 Million | $-85.03 Million | -1.133x | -20.22% |
| 2021-12-31 | $105.73 Million | $-99.68 Million | -0.943x | -40.13% |
| 2020-12-31 | $126.58 Million | $-85.17 Million | -0.673x | -371.38% |
| 2019-12-31 | $-225.81 Million | $-55.99 Million | 0.248x | -3.25% |
| 2018-12-31 | $-131.82 Million | $-33.78 Million | 0.256x | -- |
About Acutus Medical Inc
Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well a… Read more